Kingdon Capital Management, L.L.C.
13F filer · CIK 0001000097Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$976MU.S. long equity reported on 13F
Positions5618 new · 12 closed
Net flow last quarter+$36.2MBuys minus sells
Top 10 positions weight30.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202656 positions | |||||
| $54.7M | 5.60% | 2.80% | Not reported | Q4 2023 | |
| $48M | 4.92% | 0.00% | +20.0% | Q1 2025 | |
| $34.2M | 3.50% | 1.00% | +6.9% | Q3 2025 | |
| $25.4M | 2.60% | 0.14% | +33.3% | Q2 2020 | |
| $24.5M | 2.51% | 0.04% | -12.5% | Q1 2018 | |
| $23.5M | 2.40% | 0.38% | Not reported | Q4 2023 | |
| $23.2M | 2.38% | 0.76% | New | Q2 2026 | |
| $21.5M | 2.20% | 0.00% | Not reported | Q2 2023 | |
| $20.7M | 2.13% | 0.24% | Not reported | Q4 2024 | |
| $18.8M | 1.93% | Not reported | Not reported | Q4 2025 | |
| $18M | 1.84% | 0.16% | -19.2% | Q4 2024 | |
| $17.9M | 1.83% | 1.75% | Not reported | Q4 2021 | |
| $17.2M | 1.76% | 0.06% | Not reported | Q4 2025 | |
| $16.7M | 1.71% | 0.05% | +42.9% | Q3 2025 | |
| $16.1M | 1.65% | 0.02% | -14.3% | Q3 2025 | |
| $15M | 1.54% | 1.37% | +40.4% | Q3 2023 | |
| $14.8M | 1.51% | 0.01% | Not reported | Q1 2022 | |
| $14.6M | 1.49% | 0.02% | -48.6% | Q4 2020 | |
| $14.5M | 1.48% | 0.12% | +8.1% | Q1 2026 | |
| $14.3M | 1.47% | Not reported | New | Q2 2026 | |
| $13.6M | 1.39% | 0.20% | -46.4% | Q2 2023 | |
| $13.4M | 1.37% | 0.13% | Not reported | Q1 2024 | |
| $12.9M | 1.32% | 0.34% | -5.9% | Q1 2026 | |
| $12M | 1.23% | 0.19% | -12.5% | Q1 2026 | |
| $11.5M | 1.18% | 0.01% | Not reported | Q4 2022 | |
| $11.1M | 1.14% | 1.31% | Not reported | Q2 2025 | |
| $11M | 1.13% | 0.13% | -40.0% | Q3 2025 | |
| $11M | 1.12% | 0.01% | New | Q2 2026 | |
| $10.7M | 1.09% | 0.05% | -25.0% | Q1 2023 | |
| $10.2M | 1.05% | 0.04% | -22.2% | Q1 2014 | |
| $9.89M | 1.01% | 0.06% | New | Q2 2026 | |
| $9.6M | 0.98% | 0.01% | +11.1% | Q1 2017 | |
| $9.59M | 0.98% | 0.67% | +103.3% | Q1 2026 | |
| $9.49M | 0.97% | 0.21% | +25.0% | Q1 2026 | |
| $9.34M | 0.96% | 0.00% | Not reported | Q1 2024 | |
| $9.13M | 0.93% | 0.09% | -41.7% | Q4 2025 | |
| $8.99M | 0.92% | 0.03% | New | Q2 2026 | |
| $8.92M | 0.91% | 0.07% | -33.3% | Q1 2026 | |
| $8.24M | 0.84% | 2.20% | Not reported | Q1 2026 | |
| $8.02M | 0.82% | 0.59% | +11.2% | Q3 2024 | |
| $7.5M | 0.77% | 0.13% | -47.5% | Q4 2025 | |
| $7.37M | 0.76% | 0.08% | -29.0% | Q4 2014 | |
| $7.21M | 0.74% | 0.01% | Not reported | Q2 2013 | |
| $5.85M | 0.60% | 0.01% | -66.9% | Q1 2026 | |
| $5.74M | 0.59% | 0.13% | New | Q2 2026 | |
| $5.67M | 0.58% | 0.00% | -50.0% | Q2 2025 | |
| $5.65M | 0.58% | 4.40% | +23.2% | Q1 2025 | |
| $4.99M | 0.51% | 0.02% | Not reported | Q3 2013 | |
| $4.8M | 0.49% | 0.66% | New | Q2 2026 | |
| $4.09M | 0.42% | 1.28% | Not reported | Q4 2025 | |
| Q1 2026Reported May 15, 202650 positions | |||||
| $58.4M | 6.41% | 2.82% | +6.4% | Q4 2023 | |
| $34.9M | 3.83% | 0.00% | +37.9% | Q1 2025 | |
| $29M | 3.18% | 0.38% | Not reported | Q4 2023 | |
| $22.6M | 2.48% | 0.05% | -38.5% | Q1 2018 | |
| $22.2M | 2.44% | 0.93% | Not reported | Q3 2025 | |
| STSLNOSoleno Therapeutics Inc | $19.3M | 2.11% | 1.11% | +43.8% | Q3 2025 |
| $18.2M | 2.00% | 0.10% | +20.0% | Q2 2020 | |
| $17.6M | 1.93% | 0.20% | +20.5% | Q4 2024 | |
| $16.1M | 1.77% | 0.02% | -12.5% | Q3 2025 | |
| $15.2M | 1.67% | 0.00% | +12.5% | Q2 2023 | |
| $14.8M | 1.62% | 0.24% | -37.5% | Q4 2024 | |
| $14.1M | 1.55% | 0.16% | +50.0% | Q4 2025 | |
| $12.7M | 1.40% | 0.98% | -10.3% | Q3 2023 | |
| $12.7M | 1.40% | 0.37% | Not reported | Q2 2023 | |
| $12.3M | 1.36% | 0.05% | Not reported | Q1 2014 | |
| $11.8M | 1.29% | 0.12% | Not reported | Q4 2014 | |
| $11.7M | 1.28% | 0.14% | +108.1% | Q4 2025 | |
| $11.6M | 1.28% | 0.36% | New | Q1 2026 | |
| $11.5M | 1.26% | 0.05% | +84.2% | Q4 2020 | |
| $11.3M | 1.24% | 0.00% | -10.0% | Q1 2017 | |
| $11.3M | 1.24% | Not reported | Not reported | Q2 2025 | |
| $11.1M | 1.21% | 0.21% | New | Q1 2026 | |
| $11M | 1.20% | 0.07% | Not reported | Q1 2023 | |
| $10.9M | 1.20% | 0.25% | +150.0% | Q4 2025 | |
| $10.6M | 1.16% | 0.04% | -41.7% | Q3 2025 | |
| $10.6M | 1.16% | 0.23% | +5.7% | Q4 2025 | |
| $10.4M | 1.14% | 0.22% | +13.6% | Q3 2025 | |
| $10.3M | 1.13% | 0.10% | New | Q1 2026 | |
| $9.89M | 1.09% | 0.01% | Not reported | Q2 2025 | |
| $9.27M | 1.02% | 0.44% | Not reported | Q2 2014 | |
| $9.06M | 0.99% | 0.11% | New | Q1 2026 | |
| $7.48M | 0.82% | 0.46% | New | Q1 2026 | |
| $7.22M | 0.79% | 1.31% | +32.5% | Q2 2025 | |
| $7.12M | 0.78% | 0.54% | -33.7% | Q3 2024 | |
| $7.07M | 0.78% | 2.25% | New | Q1 2026 | |
| $6.48M | 0.71% | 0.11% | New | Q1 2026 | |
| $6.16M | 0.68% | 0.02% | +7.4% | Q2 2020 | |
| $6.1M | 0.67% | 0.04% | New | Q1 2026 | |
| $5.85M | 0.64% | Not reported | New | Q1 2026 | |
| $5.02M | 0.55% | 0.00% | Not reported | Q2 2014 | |
| $3.64M | 0.40% | 3.57% | +16.3% | Q1 2025 | |
| $3.63M | 0.40% | 0.33% | New | Q1 2026 | |
| $3.22M | 0.35% | 0.17% | New | Q1 2026 | |
| $3.2M | 0.35% | 1.37% | Not reported | Q4 2025 | |
| $3.01M | 0.33% | 0.04% | -33.3% | Q2 2024 | |
| $2.24M | 0.25% | 0.06% | -50.0% | Q1 2024 | |
| $2.01M | 0.22% | 0.31% | +43.1% | Q2 2023 | |
| $1.82M | 0.20% | 3.19% | Not reported | Q4 2019 | |
| $1.18M | 0.13% | 4.83% | Not reported | Q4 2021 | |
| $366K | 0.04% | 5.51% | 0.0% | Q4 2021 | |
| Q4 2025Reported Feb 17, 202655 positions | |||||
| $49.4M | 5.87% | 2.69% | -6.0% | Q4 2023 | |
| $27M | 3.21% | 0.00% | +23.4% | Q1 2025 | |
| $26.4M | 3.14% | 0.08% | Not reported | Q1 2018 | |
| $23.8M | 2.83% | 1.17% | +11.7% | Q3 2023 | |
| $23M | 2.73% | 0.38% | +14.8% | Q4 2023 | |
| $23M | 2.73% | 0.93% | +201.0% | Q3 2025 | |
| $18.7M | 2.23% | 0.02% | Not reported | Q1 2024 | |
| STSLNOSoleno Therapeutics Inc | $18.5M | 2.20% | 0.76% | +32.9% | Q3 2025 |
| $17.5M | 2.09% | 0.16% | -13.3% | Q4 2024 | |
| $17.1M | 2.03% | 0.39% | Not reported | Q4 2024 | |
| $16.4M | 1.95% | 0.02% | +45.5% | Q3 2025 | |
| $16M | 1.90% | Not reported | +42.2% | Q2 2025 | |
| $15.3M | 1.82% | 0.07% | +100.0% | Q3 2025 | |
| $15M | 1.78% | 0.00% | Not reported | Q2 2021 | |
| $14.7M | 1.74% | 0.00% | Not reported | Q1 2017 | |
| $14.3M | 1.71% | 0.09% | +15.4% | Q2 2020 | |
| $13.8M | 1.64% | Not reported | +75.0% | Q3 2025 | |
| $13.6M | 1.61% | 0.22% | New | Q4 2025 | |
| $12.9M | 1.54% | 0.07% | Not reported | Q1 2023 | |
| $12.2M | 1.45% | 0.00% | -5.9% | Q2 2023 | |
| $11.9M | 1.42% | 0.80% | +407.7% | Q3 2024 | |
| $11.7M | 1.40% | 0.00% | +25.0% | Q4 2015 | |
| $11.2M | 1.33% | Not reported | Not reported | Q1 2022 | |
| $11.2M | 1.33% | 0.19% | Not reported | Q3 2025 | |
| $11.1M | 1.32% | 0.00% | Not reported | Q2 2013 | |
| $10.6M | 1.26% | 0.02% | New | Q4 2025 | |
| $10.2M | 1.21% | 0.16% | Not reported | Q4 2024 | |
| $9.86M | 1.17% | 0.06% | Not reported | Q2 2025 | |
| $9.77M | 1.16% | 0.02% | -5.3% | Q2 2013 | |
| $9.58M | 1.14% | 3.08% | +38.9% | Q1 2025 | |
| $9.41M | 1.12% | 0.11% | New | Q4 2025 | |
| $9.28M | 1.10% | 0.01% | -16.7% | Q2 2025 | |
| $9.22M | 1.10% | 0.07% | New | Q4 2025 | |
| $9.08M | 1.08% | 0.00% | Not reported | Q3 2017 | |
| $8.63M | 1.03% | 0.35% | +5.9% | Q1 2025 | |
| $8.22M | 0.98% | 0.04% | New | Q4 2025 | |
| $7.85M | 0.93% | 0.14% | Not reported | Q1 2025 | |
| $7.67M | 0.91% | 0.02% | +35.0% | Q2 2020 | |
| $6.97M | 0.83% | 0.02% | +53.9% | Q4 2024 | |
| $6.4M | 0.76% | 0.04% | New | Q4 2025 | |
| $5.74M | 0.68% | 0.03% | -45.7% | Q4 2020 | |
| $5.52M | 0.66% | Not reported | New | Q4 2025 | |
| $5.51M | 0.65% | 0.13% | New | Q4 2025 | |
| $5.24M | 0.62% | 1.03% | -10.0% | Q2 2025 | |
| $5.17M | 0.61% | 0.01% | -50.0% | Q2 2017 | |
| $5.03M | 0.60% | 0.06% | -14.3% | Q2 2024 | |
| $4.76M | 0.57% | Not reported | Not reported | Q4 2024 | |
| $4.64M | 0.55% | 0.11% | Not reported | Q1 2024 | |
| $4.58M | 0.54% | 0.26% | New | Q4 2025 | |
| $3.86M | 0.46% | 0.02% | -60.0% | Q2 2023 | |
| Q3 2025Reported Nov 14, 202563 positions | |||||
| $38.5M | 4.77% | 2.88% | +19.1% | Q4 2023 | |
| $21.9M | 2.72% | 0.00% | -13.9% | Q1 2025 | |
| $21.1M | 2.62% | 0.22% | New | Q3 2025 | |
| STSLNOSoleno Therapeutics Inc | $20.3M | 2.53% | 0.56% | New | Q3 2025 |
| $19.6M | 2.43% | 0.04% | +175.4% | Q1 2015 | |
| $19.5M | 2.42% | 0.38% | +10.1% | Q4 2023 | |
| $18.4M | 2.28% | 0.06% | +9.3% | Q2 2014 | |
| $18.2M | 2.26% | 0.14% | +16.7% | Q3 2017 | |
| $18M | 2.23% | 0.02% | -25.0% | Q1 2024 | |
| $17.2M | 2.13% | 0.39% | Not reported | Q4 2024 | |
| $16.5M | 2.05% | 0.17% | +40.6% | Q4 2024 | |
| $14.8M | 1.83% | 0.19% | +51.6% | Q1 2024 | |
| $14.2M | 1.77% | 0.00% | Not reported | Q2 2018 | |
| $12.9M | 1.60% | 0.07% | Not reported | Q1 2023 | |
| $12.8M | 1.58% | Not reported | +18.5% | Q2 2025 | |
| $12M | 1.49% | 0.16% | +3.5% | Q4 2024 | |
| $11.9M | 1.47% | 0.00% | Not reported | Q2 2023 | |
| $11.8M | 1.46% | Not reported | Not reported | Q4 2016 | |
| CHSKYChampion Homes, Inc. | $11.5M | 1.42% | 0.27% | New | Q3 2025 |
| $11.2M | 1.39% | 0.08% | -3.7% | Q2 2020 | |
| $10.9M | 1.35% | Not reported | Not reported | Q1 2022 | |
| $10.8M | 1.34% | 0.02% | Not reported | Q2 2013 | |
| $10.8M | 1.34% | 0.01% | New | Q3 2025 | |
| $10.7M | 1.33% | 0.03% | New | Q3 2025 | |
| $10.7M | 1.33% | 0.01% | +9.1% | Q2 2025 | |
| $10.3M | 1.28% | 0.00% | Not reported | Q2 2013 | |
| $10.1M | 1.26% | 0.05% | -27.1% | Q4 2020 | |
| $9.65M | 1.20% | 0.31% | New | Q3 2025 | |
| $9.62M | 1.19% | 0.20% | New | Q3 2025 | |
| $9.5M | 1.18% | 0.05% | Not reported | Q2 2023 | |
| $9.16M | 1.14% | 0.01% | Not reported | Q1 2014 | |
| $8.86M | 1.10% | 0.06% | +8.7% | Q2 2025 | |
| $8.79M | 1.09% | 0.03% | New | Q3 2025 | |
| $8.72M | 1.08% | 2.00% | -11.8% | Q4 2021 | |
| $8.42M | 1.05% | 0.01% | Not reported | Q2 2013 | |
| $8.36M | 1.04% | 1.24% | Not reported | Q3 2023 | |
| $8.36M | 1.04% | Not reported | New | Q3 2025 | |
| $8.16M | 1.01% | 0.33% | +21.4% | Q1 2025 | |
| $8.07M | 1.00% | Not reported | New | Q3 2025 | |
| $7.29M | 0.91% | 0.00% | Not reported | Q4 2015 | |
| $7.27M | 0.90% | 0.31% | +12.6% | Q1 2021 | |
| $7.2M | 0.89% | 0.02% | -53.9% | Q2 2017 | |
| $7.18M | 0.89% | 0.01% | Not reported | Q2 2020 | |
| $6.95M | 0.86% | 2.21% | Not reported | Q1 2025 | |
| $6.56M | 0.81% | 0.01% | New | Q3 2025 | |
| $6.23M | 0.77% | 0.11% | Not reported | Q1 2024 | |
| $6.18M | 0.77% | 1.16% | +44.4% | Q2 2025 | |
| $5.84M | 0.73% | 0.07% | -44.4% | Q2 2024 | |
| $5.79M | 0.72% | 0.00% | Not reported | Q2 2013 | |
| $5.59M | 0.69% | 0.00% | Not reported | Q2 2014 | |
Premium opens every quarter this fund has filed